📰 Thomas Eldered News
Thomas Eldered News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Eldered. Real-time updates on events, politics, business and more.
October 16, 2023
Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprintNewly formed KKR platform Frontier Biosolutions and its globally renowned experts will serve as advisors to Coriolis PharmaMARTINSRIED-MUNICH, Germany, October 16, 2023 / B3C newswire / -- Coriolis Pharma, a glo...
October 16, 2023
KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and...
October 16, 2023
KKR & Co Inc (NYSE: KKR), in collaboration with Flerie, disclosed the formation of a new 
October 16, 2023
KKR and Flerie to support organic and inorganic growth to extend Coriolis’ leadership position in formulation development and analytical services for innovative high-value biologics and cell and gene therapy productsExperienced team of biopharma services veterans led by Thomas Eldered of Flerie Invest AB (“Flerie”)...
June 8, 2023
08.06.2023 - THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, ...
June 8, 2023
Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB . NorthX is a... | June 8, 2023
June 7, 2023
/PRNewswire/ -- Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases,...
June 7, 2023
The Annual General Meeting of Toleranzia AB , 556877-2866, took place today, 7 June 2023. The meeting was conducted with physical participation and by postal voting in accordance with § 9 of the... | June 7, 2023
May 12, 2023
Today, Friday 12 May 2023, the Annual General Meeting was held in Xintela AB . The following main decisions were made. The decisions were taken unanimously. Profit allocation and decision on discharge... | May 12, 2023
February 9, 2023
Prokarium's mission is to re-engineer evolution into a synthetic biology platform for novel immunotherapies Proceeds will support clinical development of the Company's lead oncology candidate